Biomarker: F004-IgE Wheat

Overview

F004-IgE Wheat measures immunoglobulin E (IgE) antibodies directed against wheat proteins in a patient’s blood. IgE is involved in immediate allergic reactions, including hives, gastrointestinal symptoms, respiratory symptoms, and anaphylaxis after wheat exposure. High wheat-specific IgE indicates sensitization and may support a diagnosis of IgE-mediated wheat allergy when consistent symptoms occur after exposure, while a low or undetectable result reduces but does not completely eliminate the possibility of allergy. The test is clinically useful as part of an allergy evaluation, but a positive result alone does not establish clinically relevant wheat allergy and may reflect asymptomatic sensitization or cross-reactivity with grass pollen.

Clinical Use Cases

Support evaluation of suspected IgE-mediated wheat allergy.
Identify sensitization to wheat in patients with immediate symptoms after eating or inhaling wheat.
Complement clinical history and skin-prick testing when evaluating food allergy.
Help assess suspected wheat-dependent exercise-induced anaphylaxis, usually with additional testing for omega-5 gliadin.
Support evaluation of occupational allergy involving wheat flour, including baker’s asthma.
Help determine whether a supervised oral food challenge may be appropriate when the diagnosis remains uncertain.
Contribute to research on wheat allergens and component-resolved allergy diagnosis.

Specimen Types

Serum, typically obtained from venous blood.
Plasma may be used with some validated specific-IgE assay systems.
Fresh whole blood may be used for research-based cellular tests such as the basophil activation test, but this is not the usual specimen for routine F004-IgE measurement.

Measurement Methods

Fluorescent enzyme immunoassay, including solid-phase assays that quantify wheat-specific IgE.
Enzyme-linked immunosorbent assay.
Chemiluminescent immunoassay.
Radioallergosorbent testing, an older method that has largely been replaced by newer immunoassays.
Component-resolved immunoassays for wheat proteins such as omega-5 gliadin, Tri a 19, gliadins, and glutenins.
Multiplex allergen microarray or immunoblot methods in selected clinical or research settings.
Basophil activation testing by flow cytometry is an adjunctive functional method, not a direct measurement of serum F004-IgE.

Test Preparation and Influencing Factors

Fasting is generally not required for a serum wheat-specific IgE test.
Antihistamines generally do not affect serum-specific IgE results, although they can suppress skin-prick test responses.
Patients should report all medications, supplements, and recent allergic reactions to the healthcare provider.
The test should be interpreted with the timing, reproducibility, and severity of symptoms after wheat exposure.
A positive result may represent sensitization without clinical allergy, particularly in people with grass-pollen sensitization because of cross-reactivity.
Wheat-specific IgE concentration does not reliably predict reaction severity, and severe reactions can occur with relatively low levels.
Results may vary between assay platforms, allergen extracts, calibration systems, and reporting units. Results from different methods should not be compared directly without clinical interpretation.
The patient should not intentionally consume wheat or undergo an oral food challenge solely to obtain a test result. Oral food challenges must be supervised by an appropriately trained clinician because of the risk of anaphylaxis.
A negative result does not exclude non-IgE-mediated wheat disorders, including celiac disease, non-celiac gluten sensitivity, or some delayed gastrointestinal reactions.